Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/39326340

Alpesh Shah; Chetan B Sangani; Jignesh H Kamdar; Khushal Kapadiya; Nishith Teraiya; Sarfaraz Ahmed; Tanzil Juneja

Sep 27, 2024